申请人:G.D. Searle & Co.
公开号:EP0235575A1
公开(公告)日:1987-09-09
The compounds of the present invention comprise substituted phenolic thioethers represented by the formula:
wherein: R₁ and R₂ are the same or different and independently represent tert-alkyl or phenyl; A represents methylene or methylene substituted by alkyl, dialkyl or hydroxy, provided that when A includes hydroxymethylene, the hydroxymethylene group is not adjacent to a heteroatom; B represents sulfur, sulfoxide, sulfone, oxygen, -NH- or nitrogen substituted by alkyl, phenyl, benzyl, substituted phenyl or substituted benzyl; C represents methylene or methylene substituted by alkyl; R₃ represents CO₂H, CO₂-alkyl or a tetrazole group; m is 0 or 1, n is 2, 3 or 4 and p is 1, 2 or 3; and the pharmaceutically acceptable salts thereof. The compounds of the present invention are specific inhibitors of 5-lipoxygenase and, therefore, are usefull in the treatment of local and systemic inflammation, allergy and hypersensitivity reactions and other disorders in which agents formed in the 5-lipoxygenase metabolic pathway are involved.
本发明的化合物包括由式表示的取代酚硫醚:
其中R₁ 和 R₂ 相同或不同,且独立地代表叔烷基或苯基;A 代表亚甲基或被烷基、二烷基或羟基取代的亚甲基,条件是当 A 包括羟基亚甲基时,羟基亚甲基不与杂原子相邻;B代表硫、亚砜、砜、氧、-NH-或被烷基、苯基、苄基、取代苯基或取代苄基取代的氮;C代表亚甲基或被烷基取代的亚甲基;R₃代表CO₂H、CO₂-烷基或四唑基;m为0或1,n为2、3或4,p为1、2或3;及其药学上可接受的盐。本发明的化合物是 5-脂氧合酶的特异性抑制剂,因此可用于治疗局部和全身性炎症、过敏和超敏反应以及其他涉及 5-脂氧合酶代谢途径的疾病。